In addition, HDAC1 maintains lung cancer cell stemness and induces a drug-resistant phenotype in lung cancer cells by inhibiting miR-200b expression and reducing the targeting of miR-200b to Suz12 (Chen et al., 2014a). Here, SUZ12 is linked to lung cancer.